Back to All Events

August 15, 2019

Zealand Pharma Interim Report for the first half of 2019


Zealand Pharma will host a conference call on August 15, 2019 at 4 pm CET/10 am EST following the announcement of results for the first six months of 2019.

Presenting during the call will be President and Chief Executive Officer Emmanuel Dulac, and Executive Vice President and Chief Medical and Development Officer Adam Steensberg, with corporate management in attendance. The presentation will be followed by a Q&A session. The conference call will be conducted in English, and the dial-in numbers are: 

Denmark........................... +45 32 72 80 42
United Kingdom........... +44 (0) 844 571 8892
United States.............…. +1 631 510 7495
France............................… +33 (0) 176700794
Netherlands.................... +31 (0) 207143545

Passcode..................... 9478582

A live audio webcast of the call, including an accompanying slide presentation, will be available via the following link, https://edge.media-server.com/m6/p/dzhe5vjk, and will be accessible on the Investor section of Zealand’s website (www.zealandpharma.com/investor). Participants are advised to register for the webcast approximately 10 minutes before the scheduled start. A recording of the event and a transcript will be available on the Investor section of Zealand’s website after the call.

If you have questions or comments, contact investors@zealandpharma.com.

Earlier Event: July 30
July 30, 2019
Later Event: August 30
August 30, 2019